Ionis Pharmaceuticals, Inc. (IONS) vs Ligand Pharmaceuticals Incorporated (LGND)
- Ionis Pharmaceuticals, Inc. IONS 39.48 +1.75%
- Ligand Pharmaceuticals Incorporated LGND 306.43 +2.48%
Ionis Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated are both Biotechnology companies. Ionis Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated are of similar size ($6.5B and $6.0B). Ionis Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Ligand Pharmaceuticals Incorporated trades at 116×. Ligand Pharmaceuticals Incorporated grew revenue faster over the last twelve months: 1.03% against −7.41%. Ligand Pharmaceuticals Incorporated has the higher net margin (20.3% vs −64.7%) and the higher return on invested capital (1.27% vs 0.00%). Across the 18 metrics below, Ligand Pharmaceuticals Incorporated leads on 14 and Ionis Pharmaceuticals, Inc. on 4.
Valuation
Profitability
| Metric | IONS | LGND | Biotechnology median |
|---|---|---|---|
| Gross margin | 98.17% | 95.22% | 65.16% |
| Operating margin | (68.00%) | 9.29% | 0.00% |
| Net margin | (64.66%) | 20.27% | 0.00% |
| Free cash flow margin | (64.93%) | 31.43% | 0.00% |
| Return on equity | (105.50%) | 5.38% | (50.12%) |
| Return on assets | (18.90%) | 2.77% | (45.60%) |
| Return on invested capital | 0.00% | 1.27% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack